Molecular Classification of Resected Primary Duodenal Adenocarcinoma
Genes, Chromosomes and Cancer · 2025
DOI: 10.1002/gcc.70061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, 2025. Verfasst von Jacob de Bakker und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Duodenal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
The molecular and histological characteristics of primary duodenal adenocarcinoma (DA) have been poorly described, which hampers the development of new treatment options. This study aimed to characterize the landscape of chromosomal copy number aberrations (CNAs), microsatellite instability status, and tumor–stroma content, and their association with clinicopathological characteristics of patients with DA.
Methods
DNA was extracted from tumor tissues of patients who underwent a primary surgical resection for DA in a single center (2000–2019). Shallow whole genome sequencing (sWGS) was performed to identify chromosomal CNAs and the genomic instability index (GII), for which 25% of the genome was altered, was used to classify tumors as CNA low or CNA high . A PCR‐based assay was performed to classify tumors as microsatellite stable (MSS) or instable (MSI). Immunohistochemistry and digital image analysis were performed to determine the tumor–stroma content, for which 50% stroma content was used to classify tumors as stroma low or stroma high .
Results
Among 74 patients with resected DA, sWGS identified 39 (52.7%) CNA low and 35 (47.3%) CNA high tumors. Overall, 16 (21.6%) DAs were MSI. All MSI tumors were CNA low . The tumor–stroma content was low in 51 (68.9%) and high in 23 (31.1%) of DAs. CNA status was most predictive for 5‐year overall survival: 45.5% for patients with CNA low compared to 31.0% for patients with CNA high DA (HR 2.20, 95% CI 1.12–4.30, p = 0.02).
Conclusion
About half of resected DAs had CNA low , which was associated with the most favorable prognosis. Subgrouping of DA could be used for patient stratification in future trials testing novel therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands.
- Cancer Center Amsterdam, Amsterdam, the Netherlands.
- Department of Pathology, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands.
- Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, the Netherlands.
- Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam, the Netherlands.
- Oncode Institute, Utrecht, the Netherlands.
ORCID-Profile: Jacob de Bakker, Tanya Soeratram, Tim de Back, Bauke Ylstra
Zitieren
APA
de Bakker, J., Biesma, H., Soeratram, T., Egthuijsen, J., de Back, T., Besselink, M., Vermeulen, L., Ylstra, B., van Grieken, N., & Kazemier, G. (2025). Molecular Classification of Resected Primary Duodenal Adenocarcinoma. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70061
Vancouver
de Bakker J, Biesma H, Soeratram T, Egthuijsen J, de Back T, Besselink M, et al. Molecular Classification of Resected Primary Duodenal Adenocarcinoma. Genes, Chromosomes and Cancer. 2025. doi:10.1002/gcc.70061
BibTeX
@article{deBakker2025,
author = {de Bakker, Jacob and Biesma, Hedde and Soeratram, Tanya and Egthuijsen, Jacqueline and de Back, Tim and Besselink, Marc and Vermeulen, Louis and Ylstra, Bauke and van Grieken, Nicole and Kazemier, Geert},
title = {Molecular Classification of Resected Primary Duodenal Adenocarcinoma},
journal = {Genes, Chromosomes and Cancer},
year = {2025},
doi = {10.1002/gcc.70061}
}
EUVIMED